METABOLIC SOLUTIONS is a pharmaceutical company focused on Metabolic, Neurology.
METABOLIC SOLUTIONS's Key Drugs
METABOLIC SOLUTIONS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
METABOLIC SOLUTIONS's Recent FDA Approvals
New NDA/BLA approvals for METABOLIC SOLUTIONS over the last two years — novel drugs only, excluding generics and label supplements.
METABOLIC SOLUTIONS's Therapeutic Areas
METABOLIC SOLUTIONS's approved drugs and pipeline span 2 therapeutic areas, led by Metabolic and Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
METABOLIC SOLUTIONS's Top Competitors
METABOLIC SOLUTIONS's closest competitors by therapeutic-area and drug-target overlap include Eli Lilly, Roche, and SPECGX LLC. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
METABOLIC SOLUTIONS Pipeline Snapshot
METABOLIC SOLUTIONS has 4 active clinical programs from ClinicalTrials.gov — 0 Phase 3, 4 Phase 2 and 0 Phase 1.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Metabolic pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1999-12-17
- Latest
- 2000-10-20
- Applications
- 1